BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26461256)

  • 1. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common data items in seven European oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper GI).
    de Steur WO; Henneman D; Allum WH; Dikken JL; van Sandick JW; Reynolds J; Mariette C; Jensen L; Johansson J; Kolodziejczyk P; Hardwick RH; van de Velde CJ;
    Eur J Surg Oncol; 2014 Mar; 40(3):325-9. PubMed ID: 24412054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
    Messager M; de Steur W; Boelens PG; Jensen LS; Mariette C; Reynolds JV; Osorio J; Pera M; Johansson J; Kołodziejczyk P; Roviello F; De Manzoni G; Mönig SP; Allum WH;
    Eur J Surg Oncol; 2016 Sep; 42(9):1432-47. PubMed ID: 26898839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010.
    Fontana E; Smyth EC; Cunningham D; Rao S; Watkins D; Allum WH; Thompson J; Waddell T; Peckitt C; Chau I; Starling N
    Gastric Cancer; 2016 Oct; 19(4):1114-1124. PubMed ID: 26541768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
    Ti TK
    Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in outcomes of oesophageal and gastric cancer surgery across Europe.
    Dikken JL; van Sandick JW; Allum WH; Johansson J; Jensen LS; Putter H; Coupland VH; Wouters MW; Lemmens VE; van de Velde CJ; van der Geest LG; Larsson HJ; Cats A; Verheij M
    Br J Surg; 2013 Jan; 100(1):83-94. PubMed ID: 23180474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.
    van der Werf LR; Wijnhoven BPL; Fransen LFC; van Sandick JW; Nieuwenhuijzen GAP; Busweiler LAD; van Hillegersberg R; Wouters MWJM; Luyer MDP; van Berge Henegouwen MI
    Ann Surg; 2019 Nov; 270(5):868-876. PubMed ID: 31634182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk adjustment models for short-term outcomes after surgical resection for oesophagogastric cancer.
    Fischer C; Lingsma H; Hardwick R; Cromwell DA; Steyerberg E; Groene O
    Br J Surg; 2016 Jan; 103(1):105-16. PubMed ID: 26607783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
    Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
    Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
    Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
    Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction.
    Reeh M; Mina S; Bockhorn M; Kutup A; Nentwich MF; Marx A; Sauter G; Rösch T; Izbicki JR; Bogoevski D
    Br J Surg; 2012 Oct; 99(10):1406-14. PubMed ID: 22961520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
    Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
    Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
    Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oesophagectomy for carcinoma of the oesophagus and oesophagogastric junction.
    Dalrymple-Hay MJ; Evans KB; Lea RE
    Eur J Cardiothorac Surg; 1999 May; 15(5):626-30. PubMed ID: 10386408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International benchmarking in oesophageal and gastric cancer surgery.
    Busweiler LAD; Jeremiasen M; Wijnhoven BPL; Lindblad M; Lundell L; van de Velde CJH; Tollenaar RAEM; Wouters MWJM; van Sandick JW; Johansson J; Dikken JL
    BJS Open; 2019 Feb; 3(1):62-73. PubMed ID: 30734017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centers?
    Hanna GB; Boshier PR; Knaggs A; Goldin R; Sasako M
    Arch Surg; 2012 Aug; 147(8):738-45. PubMed ID: 22911070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
    Busweiler LA; Henneman D; Dikken JL; Fiocco M; van Berge Henegouwen MI; Wijnhoven BP; van Hillegersberg R; Rosman C; Wouters MW; van Sandick JW;
    Eur J Surg Oncol; 2017 Oct; 43(10):1962-1969. PubMed ID: 28797755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.